ORIC Pharmaceuticals, Inc. Stock Börse Stuttgart
Equities
4TZ
US68622P1093
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7 EUR | 0.00% |
|
+6.87% | -14.11% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 507M 472M |
---|---|---|---|---|---|
Net income 2024 * | -114M -106M | Net income 2025 * | -138M -128M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.37
x | P/E ratio 2025 * |
-3.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 week | +6.87% | ||
Current month | +7.69% | ||
1 month | -16.17% | ||
3 months | -41.18% | ||
6 months | -15.66% | ||
Current year | -14.11% |
![Extreme 6.1](/images/extremecours_fleche.png)
![Extreme 6.1](/images/extremecours_fleche.png)
![Extreme 2.2](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Date | Price | Change |
---|---|---|
24-07-03 | 6.9 | -1.43% |
24-07-02 | 7 | -1.41% |
24-07-01 | 7.1 | +9.23% |
24-06-28 | 6.5 | +3.17% |
24-06-27 | 6.3 | +2.44% |
Delayed Quote Börse Stuttgart, July 03, 2024 at 02:06 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 113B | |
+18.84% | 26.22B | |
-25.37% | 19.01B | |
-20.46% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- ORIC Stock
- 4TZ Stock